- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02553408
Patients and Care Providers Perspectives and Experience With Decision Aid Tool for Self-monitoring of Blood Glucose
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The objectives of this study are to
- Describe patients' and care providers' satisfaction associated with the use of the FreeStyle Precision Neo-Meter
- Evaluate the uptake and use of the Meter
- Describe the impact of the Meter on primary care diabetes consultation from care providers' perspectives.
In order to achieve the objectives of this study, diabetes healthcare providers and people with type 2 diabetes who have been using the Neo meter will be interviewed. Maximum variability will be sought for provider discipline and patient demographic characteristics. Sampling will continue until theme saturation is reached. A total of up to 20 (10 care providers and 10 people with diabetes) will be interviewed for this study.
Diabetes healthcare provider interview: Two care providers from each discipline including physicians, nurses, nurse educators and dietitians in Southwestern Ontario, Canada, who have been using the Neo meter will be recruited for interviews. Care providers satisfaction will be assessed after the use of the Meter with sample representation of sole and team based practices.
Patient interviews: Eligible patients who agreed to participate in the study will be provided with a Neo meter and test strips. Their care providers will provide them with instructions, guidance and support in using the device as part of their self-management activities. Patients will be interviewed 3 months after (post only) the use of the Meter to assess their satisfaction with its functionality, capacity, design and ease-of-use.
Interviews will take place at a location and time convenient for participants and will take approximately 45min-60min in Oct/Nov 2015. Interviews will be audio tape recorded to allow for a fluid discussion such that the interviewer does not need to stop the conversation to take notes. A letter of information and consent form will be provided to participants.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
London, Ontario, Canada, N6A 3K7
- Western University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Individuals diagnosed with type 2 diabetes and starting basal insulin
- Inadequately managed patients i.e. patients who require further insulin intensification
- Patients who have used the Meter for at least 3 months
- Individuals who are over the age of 17
Exclusion Criteria:
- Individuals with type 1 diabetes
- Individuals who are over the age of 80
- Patients with psychological disorder
- Refuse to use the Meter to test their blood sugar
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Neo meter
This is a single arm purely qualitative (interview only) study with no comparator.
All participants will use the FreeStyle Precision Neo-Meter for at least 3 months for self-monitoring of their blood glucose.
|
Participants will receive a free glucose meter (Neo) and test strips from their care providers with education and instructions on how to use the meter to monitor their glucose level.
Three months after the start of using the meter, participants will be interviewed on their experiences, likes and dislikes about the meter.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient and Care provider satisfaction structured interview guide
Time Frame: 3 months after the use of the meter
|
Patients and Care providers will be interviewed to assess their satisfaction associated with the use of the meter and its perceived impact on diabetes management.Results will be reported in a qualitative way with participants quotes and themes that will be emerged from the interviews.
|
3 months after the use of the meter
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Stewart Harris, MD, The Western University
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Canada-IIS_ADC-OUS-IIS-14-07
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes
-
Antonio Di MauroCompletedType-2 DiabetesItaly
-
DiaMedica Therapeutics IncCompletedDiabetes Type 2Netherlands
-
RenJi HospitalUnknownType 2 Diabetes.China
-
University of Erlangen-Nürnberg Medical SchoolCompletedType 2-diabetesGermany
-
Chengdu Brilliant Pharmaceutical Co., Ltd.Not yet recruitingType 2 Diabetes Mellitus
-
Nanjing First Hospital, Nanjing Medical UniversityRecruitingType 2 Diabetes MellitusChina
-
Xiangya Hospital of Central South UniversityRecruitingType 2 Diabetes MellitusChina
-
University of Alabama at BirminghamCompletedType 2 Diabetes MellitusUnited States
-
Imperial College LondonAstraZeneca; Huma; North West London Collaboration of CCGs (NWL CCGs); Imperial...CompletedType 2 Diabetes MellitusUnited Kingdom
-
Universiti Sains MalaysiaCompleted
Clinical Trials on FreeStyle Precision Neo-Meter
-
Palo Alto Medical FoundationEmory University; Abbott Diabetes CareRecruiting
-
Abbott Diabetes CareCompletedDiabetes MellitusUnited States
-
Jaeb Center for Health ResearchNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 1United States
-
Abbott Diabetes CareCompletedDiabetes MellitusUnited Kingdom
-
Peter KristensenRecruitingDiabetes Mellitus, Type 2Denmark
-
Seoul National University HospitalInje University; Kangbuk Samsung HospitalRecruitingDiabetes Mellitus, Type 2 | Lifestyle Risk ReductionKorea, Republic of
-
Institut für Diabetes-Technologie Forschungs- und...Ascensia Diabetes CareCompleted
-
Readout, Inc.CompletedKetosis | Ketogenic DietingUnited States
-
Ascensia Diabetes CareCompleted
-
Second Military Medical UniversityUnknownAdvanced Biliary Tract Malignant TumorChina